Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by astronauts ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

Dexcom launching a OTC wearable product that makes glucose monitoring more accessible to consumers also opened up ...

DexCom is a pioneer in the development of continuous glucose monitoring (CGM) systems, which are used by people managing diabetes. Its innovative devices like the G6 and G7 have set the standard ...

StockNews.com lowered shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research report report published on Saturday. A number of other analysts have also weighed in ...

Next, we see Drury doing a routine on a trampoline while wearing one of Dexcom’s continuous glucose monitors (CGMs). In a voice-over, Jonas says, “if it feels like a diagnosis has turned your ...

The company designs, develops and focuses on commercialization of continuous glucose monitoring ... products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share.

The company designs, develops and focuses on commercialization of continuous glucose monitoring ... products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share.